UTI is the higher-quality compounder with durable OEM partnerships and better margins; LINC is the faster-growing, higher-risk expansion story trading at a significant premium.
Both LINC and UTI are benefiting from a structural shift toward skilled trade education, with a projected 3.5M technician gap by 2028. UTI is the larger, more profitable operator with exclusive OEM program partnerships, a diversified revenue stream via Concorde Healthcare, and 15.1% adj EBITDA margins. LINC is the higher-growth, earlier-stage expansion story — up 115% YTD — trading at a significant premium on every valuation metric. UTI screens better on quality, margin, and risk-adjusted return; LINC is the higher-conviction growth bet.
Full thesis
The skilled trades shortage is a decade-long structural tailwind that benefits both operators. UTI has the superior moat — exclusive OEM partnerships with Ford, BMW, Porsche, Honda, Harley-Davidson, and Freightliner create a placement rate and curriculum advantage that is genuinely hard to replicate. LINC is accelerating faster but from a smaller base, with execution risk embedded in its 22-campus, 12-state expansion. At current prices, UTI offers a better risk-reward: cheaper on EV/EBITDA (15.9x vs. ~26x), better margins, stronger FCF, and a net cash balance sheet. LINC is only compelling if you believe the enrollment ramp continues at 20%+ through 2027.
Vocational Education
A peer comparison of the two largest US for-profit trade school operators — LINC and UTI — against a backdrop of a 3.5-million technician shortage, aggressive campus expansion, and a repricing of the trade education premium.
Two Operators. One Structural Trade.
The for-profit vocational education sector has re-rated sharply in 2026. LINC is up 115% YTD; UTI is up 52% and was just added to the S&P SmallCap 600. Both are riding the same tailwind: a structural shortage of skilled trade technicians that is getting worse faster than 4-year colleges or community colleges can address it. The question at current prices isn't whether the thesis works — it's which name you're paying up for and what you're getting for that premium.
The Structural Tailwind
The US faces a projected shortage of 3.5 million skilled trade workers by 2028. Automotive technicians, diesel mechanics, HVAC specialists, and industrial electricians — the exact programs offered by LINC and UTI — are among the hardest-hit categories. Average starting wages for automotive technicians have risen to $52,000–$70,000+, competitive with many 4-year degree paths at a fraction of the time and cost.
The cultural stigma around trade education is eroding. Federal workforce development funding is growing. Baby Boomer retirements are accelerating the technician shortage faster than the pipeline can replenish. Both LINC and UTI are positioned to absorb the demand — the question is how well each executes the capacity build-out.
Demand Drivers
- Technician shortage 3.5M projected gap by 2028 (Deloitte)
- Wage parity Avg auto tech wages $52K–$70K+, competitive with 4-yr outcomes
- Boomer retirements Accelerating supply-side shortage in trades
- EV complexity New EV/hybrid drivetrain certification demand from OEMs
- Federal support Workforce development funding growing under current policy
Key Risks to Watch
- Title IV concentration Both depend heavily on federal student loan/Pell grant eligibility
- Consumer credit Lower-income student cohorts sensitive to tuition financing conditions
- Regulatory risk DOE gainful employment rules historically volatile
- Campus execution New openings face cost overruns and slower enrollment ramps
- Macro softening Enrollment decisions lag consumer confidence
Market Cap Breakdown
Full Comparison
| Company | Price | Mkt Cap | YTD | 52-wk Range | TTM P/E | FWD P/E | P/S TTM | EV/EBITDA | Rev YoY | EBITDA Mgn | Net Margin | Net Cash | Consensus PT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LINC Lincoln Educational Services | $50.50 | $1.60B | +114.8% | $17.29–$53.50 | ~80x | ~64x | 3.1x | ~26x ~est. | +17.8% | ~11% ~est. | 3.9% | ~$100M | $55.40 |
| UTI Universal Technical Institute | ~$38.00 | $2.09B | +52% | $21.29–$44.87 | 33x | ~49x | 2.5x | 15.9x | +14.0% | 15.1% | 7.5% | ~$82M | ~$42–$45 |
All data as of June 5, 2026. LINC FY ends December 31; UTI FY ends September 30 — periods are not directly comparable. FWD P/E uses company FY2026 EPS guidance midpoints. EBITDA margins marked ~est. are calculated from company-reported quarterly adj. EBITDA; gross margin data unavailable for LINC at time of publication. See footnote for sources.
Lincoln Educational operates 22 trade and vocational campuses across 12 states, offering programs in automotive technology, diesel mechanics, HVAC, electrical systems, and healthcare technology. The company is in an aggressive campus expansion phase funded by operating cash flow, with a zero-debt balance sheet and $100M+ liquidity. Three consecutive years of double-digit revenue growth have earned it a premium multiple — but at ~80x trailing earnings, the stock prices in execution on every new campus.
LINC's competitive advantage rests on employer partnerships and accreditation. The company has relationships with Volvo, major automotive OEMs, and regional employers that provide direct hiring pipelines for graduates. That placement track record is what justifies tuition and sustains enrollment. The moat is real but narrower than UTI's — LINC lacks the exclusive OEM curriculum partnerships that give UTI a curriculum differentiation that employers pay to access.
| Level | Description | Price |
|---|---|---|
| R4 | High analyst target | $60.00 |
| R3 | Analyst target (Rosenblatt) | $60.00 |
| R2 | Consensus avg target | $55.40 |
| R1 | 52-week high | $53.50 |
| — | Current price (Jun 5) | $50.50 |
| S1 | Recent consolidation floor | $45.00 |
| S2 | April breakout level | $39.00 |
| S3 | Q1 2026 gap level | $30.00 |
| S4 | Pre-2026 base | $22.00 |
Scenarios — 12-Month Forward View
Near-Term Catalysts
Upcoming Events
- Q2 2026 earnings (Aug) Next data point on enrollment growth rate — market watching closely for any deceleration from Q1's +19.5% starts.
- New campus openings (2026) LINC is spending $70–75M in capex in 2026. Execution on new campus ramp times is the biggest near-term risk to estimates.
- FY2026 guidance revision Already raised once after Q1. A second raise would validate the bull case and likely push the stock toward $60.
- Title IV regulatory environment Any DOE rulemaking on gainful employment standards or accreditor oversight creates headline risk regardless of LINC's compliance record.
Fundamental Snapshot
- Revenue FY2025 $518.2M (+17.8% YoY)
- Q1 2026 Revenue $144.0M (+22.5% YoY)
- FY2026 Rev Guidance $590–$600M
- Adj EBITDA Guidance $76–$80M
- EPS Guidance $0.74–$0.83
- Campuses / States 22 campuses / 12 states
- Students Enrolled ~17,046
- Debt $0 (revolving line $125M unused)
- PW Value (30/50/20) ~$55.60
How I'm thinking about it: LINC has earned its re-rating. The execution record is three years of double-digit growth with expanding margins and zero debt. At $50.50, though, you're paying ~80x trailing earnings and ~26x estimated EBITDA for a business that still needs to prove the new campuses ramp on schedule. The stock is not cheap on any traditional metric. I'd be a buyer closer to $42–$45 where the risk-reward becomes more interesting. If Q2 enrollment numbers surprise to the upside, $60+ is in play by year-end — but that's a momentum trade, not a value one.
Universal Technical Institute is the largest for-profit trade school operator in the US, running automotive, diesel, motorcycle, marine, and welding programs under the UTI brand, plus healthcare programs through its Concorde Career Colleges acquisition. UTI's structural differentiator is its exclusive OEM Preferred Education Program partnerships — Ford, GM, BMW, Porsche, Honda, Harley-Davidson, and Freightliner all embed manufacturer-specific training curricula at UTI campuses, creating a placement advantage that drives enrollment demand and is genuinely hard to replicate. FY2025 revenue of $835.6M grew 14% and adj EBITDA was $126.5M at a 15.1% margin — materially better operating leverage than LINC.
UTI's OEM partnership model is the strongest competitive advantage in this peer group. When a BMW or Porsche dealer hires a UTI graduate who completed the manufacturer-certified track, they're getting a technician trained on factory equipment with OEM-approved curriculum — something no community college can replicate and no new entrant can license overnight. This creates a network effect: OEM certification drives employer hiring preference, which drives enrollment, which sustains the OEM relationship. It's a flywheel that LINC's employer partnerships approximate but don't match in depth or exclusivity.
| Level | Description | Price |
|---|---|---|
| R4 | Rosenblatt target | $45.00 |
| R3 | 52-week high | $44.87 |
| R2 | Barrington / avg target | $42.00 |
| R1 | Pre-pullback high area | $40.00 |
| — | Current price (~Jun 5) | ~$38.00 |
| S1 | Recent range floor | $34.00 |
| S2 | Q4 2025 range | $30.00 |
| S3 | Pre-2026 consolidation | $26.00 |
| S4 | 52-week low | $21.29 |
Scenarios — 12-Month Forward View
Near-Term Catalysts
Upcoming Events
- Q3 FY2026 earnings (Aug 2026) Following a softer Q2 (adj EBITDA $14.1M on campus expansion costs), Q3 is the pivotal data point. Management guided Q4 as the strongest growth quarter.
- Concorde integration milestones Healthcare education segment progress toward profitability is a key margin catalyst. Any update on timeline to breakeven moves the stock.
- New OEM partnership announcements Any expansion of the OEM Preferred Education Program (e.g., new EV certification track, new OEM added) validates the structural moat.
- FY2029 roadmap progress Management has committed to $1.2B+ revenue and ~$220M adj EBITDA by FY2029. Early evidence of the ramp matters to long-term bulls.
Fundamental Snapshot
- Revenue FY2025 $835.6M (+14.0% YoY)
- Adj EBITDA FY2025 $126.5M (15.1% margin)
- FCF FY2025 $55.4M (6.6% FCF margin)
- FY2026 Rev Guidance $905–$915M (+9%)
- FY2026 Adj EBITDA Guidance $114–$119M
- FY2026 EPS Guidance $0.71–$0.80
- Cash + ST Investments ~$169M
- Total Debt $87.1M (Net cash: ~$82M)
- PW Value (30/50/20) ~$44.40
How I'm thinking about it: UTI is the better business at current prices. The OEM partnership moat is durable, the balance sheet is clean, and the $1.2B revenue target by FY2029 is credible given the current trajectory. The stock pulled back from its $44.87 high (near the S&P 600 inclusion spike) to around $38 — that's a better entry than chasing the May momentum. The near-term headwind is the campus expansion investment cycle that's compressing EBITDA in FY2026; if you can look through that to FY2027 margin recovery, the stock screens attractively at 15.9x EV/EBITDA. Up/down of 1.5:1 to my $45 base/$27 bear is acceptable for a high-conviction trade thesis.
Where the Value Is
Both names work in the bull case. The structural tailwind is real, the enrollment growth is confirmed, and the skilled trades shortage is not a 12-month story — it's a decade. The question is what you're paying for that exposure.
UTI is the better risk-adjusted bet. It's larger, more profitable, has a structurally superior moat via OEM partnerships, generates real FCF, and trades at 15.9x EV/EBITDA versus LINC's estimated ~26x. The FY2026 margin compression from campus expansion is real but temporary and known. An investor buying UTI at $38 gets a business with a credible path to $1.2B revenue and ~$220M adj EBITDA by FY2029 — paid for today at a modest premium to fair value.
LINC is the growth story, not the quality story. At $50.50 and 80x trailing earnings, you're paying for execution on a campus build-out that hasn't happened yet. The stock is already up 115% YTD and is within 6% of analyst consensus target. That's a low margin of safety for a name that needs to keep posting 20%+ enrollment growth. If you already own it from below $30, the base case is to hold toward $56; if you don't own it, the better add is closer to $42–$45 where the valuation is less punishing.
| Name | View | Current | Bull (30%) | Base (50%) | Bear (20%) | PW Value | Up / Down |
|---|---|---|---|---|---|---|---|
| LINC — Lincoln Educational | HOLD / BUY <$45 | $50.50 | $70 | $56 | $33 | $55.60 | 1.1 : 1 |
| UTI — Universal Technical | BUY | ~$38.00 | $55 | $45 | $27 | $44.40 | 1.5 : 1 |
PW Value = probability-weighted average of bull, base, and bear targets. Up/Down = (bull − current) / (current − bear). These are illustrative analytical exercises only — not investment recommendations.
Data Sources & Disclosures
Report Date: June 5, 2026 · Hammockistan · Peer Analysis · Vocational Education
Price data: LINC price of $50.07 confirmed via web search as of June 3–4, 2026; reported as $50.50 est. for June 5. UTI price of $37.41 confirmed as of May 29, 2026; reported as ~$38.00 est. for June 5. All prices approximate — verify current quotes before acting.
52-week ranges: LINC $17.29–$53.50 confirmed via web search. UTI $21.29–$44.87 confirmed via web search. One source cited UTI 52-week high as $41.50 (May 14, 2026 close); $44.87 intraday high used as reported by multiple sources.
YTD performance: LINC +114.8% confirmed via Simply Wall St / public.com. UTI +52% per web search; 1-year total return cited as +20% from one source vs. 52% YTD — discrepancy reflects calendar-year YTD vs. trailing-12-month framing.
Financial data: LINC FY2025 revenue $518.2M and net income ~$20M from SEC 10-K filing (Dec 2025). Q1 2026 results from May 11, 2026 earnings release. FY2026 guidance from May 2026 raised guidance announcement. UTI FY2025 data from November 19, 2025 press release (FY ending Sep 30, 2025). Q2 FY2026 data from May 2026 earnings call. FY2026 guidance as reiterated.
Estimated / unverified metrics (~est.): LINC adj EBITDA FY2025 (~$57M) estimated from quarterly reported figures; LINC adj EBITDA margin (~11%) derived from that estimate. LINC gross margin not publicly available at report date — marked N/A in analysis. UTI gross margin (~49.65%) sourced from third-party analysis; treat as approximate.
Analyst data: LINC — avg target $55.40, 4–5 analysts, Strong Buy consensus (MarketBeat, Public.com, TipRanks). UTI — Barrington target $42, Rosenblatt target $45, 13 Buy ratings, 0 Hold/Sell (TipRanks, Yahoo Finance).
Scenario probabilities and price targets are illustrative analytical exercises only. They represent a structured framework for thinking about risk/reward, not forecasts. The author may hold positions in securities mentioned. Nothing in this report constitutes investment, financial, tax, or legal advice. Do your own research and consult a licensed financial professional before making investment decisions.